Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies

Nazmi, Aydin; Victora, Cesar G.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p212
Academic Journal
Background: Socioeconomic and racial/ethnic factors strongly influence cardiovascular disease outcomes and risk factors. C-reactive protein (CRP), a non-specific marker of inflammation, is associated with cardiovascular risk, and knowledge about its distribution in the population may help direct preventive efforts. A systematic review was undertaken to critically assess CRP levels according to socioeconomic and racial/ethnic factors. Methods: Medline was searched through December 2006 for population-based studies examining CRP levels among adults with respect to indicators of socioeconomic position (SEP) and/or race/ethnicity. Bibliographies from located studies were scanned and 26 experts in the field were contacted for unpublished work. Results: Thirty-two relevant articles were located. Cross-sectional (n = 20) and cohort studies (n = 11) were included, as was the control group of one trial. CRP levels were examined with respect to SEP and race/ethnicity in 25 and 15 analyses, respectively. Of 20 studies that were unadjusted or adjusted for demographic variables, 19 found inverse associations between CRP levels and SEP. Of 15 similar studies, 14 found differences between racial/ethnic groups such that whites had the lowest while blacks, Hispanics and South Asians had the highest CRP levels. Most studies also included adjustment for potential mediating variables in the causal chain between SEP or race/ethnicity and CRP. Most of these studies showed attenuated but still significant associations. Conclusion: Increasing poverty and non-white race was associated with elevated CRP levels among adults. Most analyses in the literature are underestimating the true effects of racial/ethnic and socioeconomic factors due to adjustment for mediating factors.


Related Articles

  • Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Grandi, Norma Christine; Breitling, Lutz Philipp; Hahmann, Harry; Wüsten, Bernd; Miärz, Winfred; Rothenbacher, Dietrich; Brenner, Hermann // Heart;Aug2011, Vol. 97 Issue 15, p1215 

    Background and objective Recent longitudinal studies have suggested an association of high serum parathyroid hormone levels (PTH) with elevated cardiovascular risk in the general population. This study presents analyses of the prognostic value of baseline PTH for subsequent cardiovascular events...

  • Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? Ridker, Paul M. // Annals of Internal Medicine;06/01/99, Vol. 130 Issue 11, p933 

    Assesses five risk factors for cardiovascular diseases. Lipoprotein; Total plasma homocysteine; Fibrinolytic capacity; Fibrinogen; High-sensitivity C-reactive protein; Guidelines to assist physicians in deciding whether these novel markers deserve clinical consideration in general outpatient...

  • New studies.  // MLO: Medical Laboratory Observer;Nov2002, Vol. 34 Issue 11, p9 

    Reports on classification of cardiovascular risk by combining coronary calcium scores in nondiabetic patients. Use of computed tomography scan and C-reactive protein levels for measuring the scores; Relationship between elevated calcium scores and future coronary events.

  • Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis. Vadakayil, Asha Ramay; Dandekeri, Sukumar; Kambil, Srinath M.; Ali, Neema M. // Indian Dermatology Online Journal;Sep/Oct2015, Vol. 6 Issue 5, p322 

    Background: There is a paucity of studies addressing the elevation of C-reactive protein (CRP) among psoriatic patients and the role of this marker in assessment of disease severity and association with cardiovascular diseases (CVDs). Objective: To assess the difference in CRP levels between...

  • Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis. Fadini, Gian Paolo; Maruyama, Shoichi; Ozaki, Takenori; Taguchi, Akihiko; Meigs, James; Dimmeler, Stefanie; Zeiher, Andreas M.; Kreutzenberg, Saula de; Avogaro, Angelo; Nickenig, Georg; Schmidt-Lucke, Caroline; Werner, Nikos // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    Background: Circulating progenitor cells (CPC) contribute to the homeostasis of the vessel wall, and a reduced CPC count predicts cardiovascular morbidity and mortality. We tested the hypothesis that CPC count improves cardiovascular risk stratification and that this is modulated by low-grade...

  • Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status. Kengne, Andre Pascal; Batty, G. David; Hamer, Mark; Stamatakis, Emmanuel; Czernichow, Sébastien // Diabetes Care;Feb2012, Vol. 35 Issue 2, p396 

    OBJECTIVE--C-reactive protein (CRP) is associated with the risk of cardiovascular disease (CVD); whether the effects are modified by diabetes status still is unclear. This study investigated these issues and assessed the added value of CRP to predictions. RESEARCH DESIGN AND...

  • C-reactive Protein Predicts Systolic Blood Pressure and Pulse Pressure but not Diastolic Blood Pressure: the Cardiovascular Disease Risk Factors Two-Township Study. Chuang, Shao-Yuan; Hsu, Pai-Feng; Chang, Hsing-Yi; Bai, Chyi-Huey; Yeh, Wen-Ting; Pan, Harn-Wen // American Journal of Hypertension;May2013, Vol. 26 Issue 5, p657 

    OBJECTIVE Inflammation has been associated with cardiovascular events and mortality, using C-reactive protein (CRP) as a marker. We examined whether the baseline serum concentration of CRP can independently predict the development of hypertension or future systolic or diastolic blood pressure...

  • Too Little--or Too Much--Vitamin D Bad for Your Heart.  // Tufts University Health & Nutrition Letter;Apr2012, Vol. 30 Issue 2, p3 

    The article discusses a study which revealed the association between increasing blood levels of vitamin D and decreasing amounts of C-reactive protein (CRP), a marker of inflammation linked to greater risk of heart problems. It also reports the increase in daily levels for vitamin D, for...

  • The Effects of Tibolone on Risk Factors of Cardiovascular Disease in Menopausal Women. Ziaei, Saeideh; Vakilinia, Tahereh; Faghihzadeh, Soghrat // Iranian Journal of Medical Sciences;Dec2010, Vol. 35 Issue 4, p281 

    Background: Tibolone is frequently used as a hormone-like alternative to traditional HRT. Therefore, it is valuable to compare the effects of tibolone and HRT on cardiovascular diseases risk factors. Methods: A total of 156 healthy non-surgical postmenopausal women were included in an open...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics